根据以色列的数据。辉瑞疫苗对印度变种至少有一部分作用。 ‘Double Mutant’ Covid Variant: Here’s What We Know As Israel Reports Vaccine Efficacy Against Variant First Detected In India Israeli health officials on Tuesday reported the Pfizer-BioNTech vaccine is at least partially effective against the potentially worrisome Indian variant of the coronavirus which has been rapidly spreading in India’s worst-hit Covid-19 hotspots and is being viewed as the likely culprit behind the country’s devastating second wave. https://www.forbes.com/sites/siladityaray/2021/04/20/double-mutant-covid-variant-heres-what-we-know-as-israel-reports-vaccine-efficacy-against-variant-first-detected-in-india/ Israel on Tuesday registered eight cases caused by the Indian variant—mostly among people arriving from abroad—and reported that the Pfizer-BioNTech vaccine “has efficacy against it, albeit a reduced efficacy,” Reuters reported.
印度在一月已经测出有50%以上的群体免疫，现在还是新冠大爆发！说明即使打疫苗得到的旧抗体也根本没有用！！！ 疫苗财团当然是打的越多，赚的越多。打了疫苗，对同样的变异有效果是没错的。可是对新变种看来效果甚微。以色列打全疫苗的到达55%，美国更低。可是印度在一月底测出50%-60%的人已经有新冠抗体，也就是说他们已经得过新冠而且康愈。那时候也是印度经过第一波降的最低的时候，见图。可是新变种一点都不客气，一下子来个超级第三波。也就是说，即使有抗体，你还是会得新冠新变异，也会继续传人。 大家打了疫苗，不要以为没事了，新冠没几个月换一波变异。还是要格外小心！ https://www.webmd.com/lung/news/20210129/herd-immunity-in-sight-for-indias-capital Preliminary results show that more than 60% of residents in one district in Delhi had antibodies against the coronavirus. The antibody rate in other districts more than 50%. If these findings hold true, it would imply that half of the city''s 20 million people has been exposed to the virus and recovered.
‘Double Mutant’ Covid Variant: Here’s What We Know As Israel Reports Vaccine Efficacy Against Variant First Detected In India
Israeli health officials on Tuesday reported the Pfizer-BioNTech vaccine is at least partially effective against the potentially worrisome Indian variant of the coronavirus which has been rapidly spreading in India’s worst-hit Covid-19 hotspots and is being viewed as the likely culprit behind the country’s devastating second wave.
https://www.forbes.com/sites/siladityaray/2021/04/20/double-mutant-covid-variant-heres-what-we-know-as-israel-reports-vaccine-efficacy-against-variant-first-detected-in-india/
Israel on Tuesday registered eight cases caused by the Indian variant—mostly among people arriving from abroad—and reported that the Pfizer-BioNTech vaccine “has efficacy against it, albeit a reduced efficacy,” Reuters reported.
这个我很早就看到了，要看滴度还有多少，下降了多少倍，等文章吧。印度的数据是他们自己的灭活疫苗中和滴度下降了两倍左右，不过这个疫苗起点不算高
👍请问两倍滴度的数据有链接吗？
印度政府抗疫不力，责任完全在印方！
文章在这里，最后一个图 https://www.biorxiv.org/content/10.1101/2021.04.23.441101v1.full.pdf
相比之下南非变种是一半左右的康复血清直接悲剧，完全失去对病毒的中和能力
照这个理论，人类出生就应该被真空分别隔绝保护起来，不受任何病毒侵害，不给任何传播的机会，这就是上策？
这倒不一定 因为会筛出来越来越容易传播的病毒 但是越来越容易传播的不等于越来越致命
筛出来的是突破了目前的疫苗/自然产生的抗体的病毒，致命程度倒是可强可弱。就从目前印度的趋势来看，筛出来的是个毒性挺强的病毒，印度抗疫虽然一直是躺平，但是这样大规模的死人还是头一遭。
我有种感觉，这个印度变种如果真是口鼻流血，一堆青壮年重症，会不会太致命了反而在印度以外其他国家，特别是发达国家传不太开
新冠杀人不够快，有潜伏期，才会造成大规模传播和伤亡。目前看来印度变种也是这个德行，不然不会在印度传染得这么厉害。当初非典之所以能很快控制就是因为没潜伏期，有症状的才会传染，很容易甄别。
我只能希望几个药厂赶紧先做体外实验，好歹给我们吃个定心丸。
我感觉无论什么东西到了印度，都不能按常理推断了… 非典在印度估计也能传的开。。。
疫苗财团当然是打的越多，赚的越多。打了疫苗，对同样的变异有效果是没错的。可是对新变种看来效果甚微。以色列打全疫苗的到达55%，美国更低。可是印度在一月底测出50%-60%的人已经有新冠抗体，也就是说他们已经得过新冠而且康愈。那时候也是印度经过第一波降的最低的时候，见图。可是新变种一点都不客气，一下子来个超级第三波。也就是说，即使有抗体，你还是会得新冠新变异，也会继续传人。
大家打了疫苗，不要以为没事了，新冠没几个月换一波变异。还是要格外小心！
https://www.webmd.com/lung/news/20210129/herd-immunity-in-sight-for-indias-capital Preliminary results show that more than 60% of residents in one district in Delhi had antibodies against the coronavirus. The antibody rate in other districts more than 50%. If these findings hold true, it would imply that half of the city''s 20 million people has been exposed to the virus and recovered.
新贴给封存了啊。没办法，得提醒大家打了疫苗也不能大意啊。我喜欢独立分析和然后大家分享讨论。
其实如果真的弱到像一个感冒那样就没什么了，敲木头！
这个不是 上策是 临时的，。。。。。
这个论文我也看到了，我们现在的分析是这个b.1.167可能和brazil变种传染性相当或稍弱，两个mRNA疫苗应该都有用，等大数据。
最可怕的是看到文章说Pfizer疫苗对南非变种有ADE效应。。。